DropXcell Corp. reposted this
What is the #1 thing that pharma CEOs are worried about for 2024? At this years #jpm2024 conference, Accenture hosted a roundtable with CEOs of 12 of the top #pharmaceutical companies, leading to the bold claim that keeping up with advanced technology is their biggest concern for 2024. That's right: the pace of new technology development is so fast, that now CEO's are worried about how they will be able to properly implement these new technologies in order to secure a competitive advantage. Technology--like AI, high-throughput screens, and -omics--is the new competitive frontier in the pharmaceutical industry, and will drive success or failure across the sector. Companies like Amgen believe that they can use technology to cut antibody discovery timelines in half, while Generate Biomedicines' CEO believes that technology will help drug development transform from an artisanal craft to an engineered process. The good news for the CEOs is that companies like DropXcell are here to help. Our expertise in high-throughput, function-focused discovery of antibodies will help the CEOs of the world transform their antibody discovery pipelines to be able to screen millions of antibodies for function, rather than binding. This is poised to be a very exciting 2024 for the industry and for DropXcell, and we look forward to working together to bring new technology to pharmaceutical drug discovery.